The management of laryngeal and tracheal stenosis continues to challenge us, despite advances in surgical techniques and better understanding of the wound healing process. Injury to the airway mucosa is the inciting event, regardless of the cause of the stenosis. Mitomycin-C is an antineoplastic antibiotic that acts as an alkylating agent by inhibiting DNA and protein synthesis. It can inhibit cell division, protein synthesis, and fibroblast proliferation. Topical application of mitomycin-C (0.4 mg/mL) was used as an adjuvant treatment in the endoscopic laser management of laryngeal and tracheal stenosis in 15 patients. Fourteen patients (93%) have shown improvement of their airway and resolution of their preoperative symptoms. After a mean follow-up of 18 months, no complication was noted with regard to the application of mitomycin-C. This study gives promising findings on the efficacy and safety of mitomycin-C as an adjuvant treatment in the management of selected cases of laryngeal and tracheal stenosis.
RahbarRValdezTAShapshaySM. Preliminary results of intraoperative mitomycin C in the treatment and prevention of glottic and subglottic stenosis. J Voice2000; 14: 282–6.
2.
ShapshaySMBeamisJFHybelsRLBohigianRK. Endoscopic treatment of subglottic and tracheal stenosis by radial laser incision and dilation. Ann Otol Rhinol Laryngol1987; 96: 661–4.
3.
KleinsasserO. Microlaryngoscopy and endolaryngeal microscopy. Philadelphia, Pa: WB Saunders, 1968.
4.
PolanyiTGBredemeierHCDavisTW. A co2 laser for surgical research. Med Biol Eng Comput1970; 8: 541–8.
5.
ShapshaySMSimpsonGT. Lasers in bronchology. Otolaryngol Clin North Am1983; 16: 879–86.
6.
StrongMSJakoGJ. Laser surgery in the larynx. Early clinical experience with continuous co2 laser. Ann Otol Rhinol Laryngol1972; 81: 791–8.
7.
StromeM. Cryosurgery: The effect on the canine endolaryngeal structures. Laryngoscope1971; 81: 1057–65.
8.
FriedmanEMHealyGBMcGillTJ. Carbon dioxide laser management of subglottic and tracheal stenosis. Otolaryngol Clin North Am1983; 16: 871–7.
9.
StrongMSHealyGBVaughanCWFriedMPShapshaySM. Endoscopic management of laryngeal stenosis. Otolaryngol Clin North Am1979; 12: 797–805.
10.
HealyGB. An experimental model for the endoscopic correction of subglottic stenosis with clinical applications. Laryngoscope1982; 92: 1103–15.
11.
ShapshaySMBeamisJFDumonJ-F. Total cervical tracheal stenosis: Treatment by laser, dilation, and stenting. Ann Otol Rhinol Laryngol1989; 98: 890–5.
12.
StrongMSJakoGJPolanyiTGWallaceRA. Laser surgery in the aerodigestive tract. Am J Surg1973; 126: 529–33.
13.
DedoHHSooyCD. Endoscopic laser repair of posterior glottic, subglottic, and tracheal stenosis by division or micro-trapdoor flap. Laryngoscope1984; 94: 445–50.
AndrewsAAHorowitzSL. Bronchoscopic co2 laser surgery. Lasers Surg Med1980; 1: 35–9.
16.
SimpsonGTStrongMSHealyGBShapshaySMVaughanCW. Predictive factors of success or failure in the endoscopic management of laryngeal and tracheal stenosis. Ann Otol Rhinol Laryngol1982; 91: 384–8.
17.
CarruthAS. The role of lasers in otolaryngology. World J Surg1983; 7: 719–22.
18.
OssoffRHTuckerGFDuncavageJAToohillRJ. Efficacy of bronchoscopic carbon dioxide laser surgery for benign strictures of the trachea. Laryngoscope1985; 95: 1220–3.
19.
SeraVRHallKLowHGrowth factors: From genes to clinical application. New York, NY: Raven Press, 1990.
20.
BorderWARuoslahtiE. Transforming growth factor-β in disease: The dark side of tissue repair. J Clin Invest1992; 90: 1–7.
21.
CrouchE. Pathobiology of pulmonary fibrosis. Am J Physiol1990; 259: 159–84.
22.
DoolinEJStrandeLFTsunoKSantosMC. Pharmacologic inhibition of collagen in an experimental model of subglottic stenosis. Ann Otol Rhinol Laryngol1998; 107: 275–9.
23.
IngramsDRAshtonPDhingraJShahRShapshaySM. Slow-release 5-fluorouracil and triamcinolone reduces subglottic stenosis in a rabbit model. Ann Otol Rhinol Laryngol2000; 109: 422–4.
24.
KunitomoNMoriS. Studies on the pterygium. Part IV. A treatment of the pterygium by mitomycin-C instillation. Acta Soc Ophthalmol Jpn1963; 67: 601–7.
25.
ChenC. Enhanced intraocular pressure controlling effectiveness of trabeculectomy by local application of mitomycin-C. Trans Asia-Pacific Acad Ophthalmol1983; 9: 172–7.
26.
PalmerS. Mitomycin as adjunct chemotherapy with trabeculectomy. Ophthalmology1991; 98: 317–21.
27.
BergstromTJWilkinsonWSSkutaGLWatnickRLElnerVM. The effects of subconjunctival mitomycin-C on glaucoma filtration surgery in rabbits. Arch Ophthalmol1991; 109: 1725–30.
28.
DesmouliereARedardMDarbyIGabbianiG. Apoptosis mediates the decrease in cellularity during the transition between granulation tissue and scar. Am J Pathol1995; 146: 56–66.
29.
LeeDALeeTCCortesAEKitadaS. Effects of mithramycin, mitomycin, daunorubicin, and bleomycin on human subconjunctival fibroblast attachment and proliferation. Invest Ophthalmol Vis Sci1990; 31: 2136–44.
30.
KhawPTDoyleJWSherwoodMBGriersonISchultzGSMcGorrayS. Prolonged localized tissue effects from 5-minute exposures to fluorouracil and mitomycin C. Arch Ophthalmol1993; 111: 263–7.
31.
PalmerSS. Mitomycin as adjunct chemotherapy with trabeculectomy. Ophthalmology1991; 98: 317–21.
32.
UrbanRCKaufmanLM. Mitomycin in the treatment of hypertrophic conjunctival scars after strabismus surgery. J Pediatr Ophthalmol Strabismus1994; 31: 96–8.
33.
KaoSCSLiaoCLTsengJHSChenMSHouPK. Dacryocystorhinostomy with intraoperative mitomycin. Ophthalmology1997; 104: 86–91.
34.
RubinfeldRSSteinRM. Topical mitomycin-C for pterygia: Is single application appropriate?Ophthalmic Surg Lasers1997; 28: 662–9.
35.
SchipperISuppeltCGebbersJ. Mitomycin-C reduces scar formation after excimer laser (193) photorefractive keratectomy in rabbits. Eye1997; 11: 649–55.
36.
LeeDA. Antifibrosis agent in glaucoma surgery. Invest Ophthalmol Vis Sci1994,35: 3789–91.
